Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 202
Filtrar
1.
Heart Surg Forum ; 24(3): E575-E577, 2021 Jun 23.
Artigo em Inglês | MEDLINE | ID: mdl-34173769

RESUMO

Severe bronchospasm during cardiopulmonary bypass is an unusual but potentially fatal event. No literature previously has reported such an event observed during surgery for type A aortic dissection. Herein, we report on a case of severe bronchospasm following cardiopulmonary bypass, during aortic surgery for type A aortic dissection. Bronchospasm did not respond to any conventional therapy, necessitating extracorporeal membrane oxygenation. Extracorporeal membrane oxygenation thus serves as an alternative and effective therapy for refractory bronchospasm.


Assuntos
Aneurisma da Aorta Torácica/cirurgia , Dissecção Aórtica/cirurgia , Espasmo Brônquico/etiologia , Oxigenação por Membrana Extracorpórea/métodos , Complicações Intraoperatórias/etiologia , Procedimentos Cirúrgicos Vasculares/efeitos adversos , Dissecção Aórtica/diagnóstico , Aneurisma da Aorta Torácica/diagnóstico , Espasmo Brônquico/diagnóstico , Espasmo Brônquico/terapia , Broncoscopia , Angiografia por Tomografia Computadorizada , Humanos , Complicações Intraoperatórias/diagnóstico , Complicações Intraoperatórias/terapia , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença
2.
BMC Pediatr ; 18(1): 377, 2018 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-30501615

RESUMO

BACKGROUND: Bordetella pertussis can cause fatal illness with severe acute respiratory distress syndrome (ARDS) and pulmonary hypertension (PHT). CASE PRESENTATION: A 6-month-old non-vaccinated boy with B. pertussis infection who developed ARDS was treated by extracorporeal membrane oxygenation (ECMO). During his ECMO support stage, sudden occurred decreasing of ECMO flow implied increasing intrathoracic pressure. The airway spasm followed caused sudden drop of ventilator tidal volume as well as poor lung compliance. Prone position ventilation and bundle care were conducted as lung protection ventilator strategy. After 297-h of ECMO support, the patient was weaned off ECMO, and extubated one week later. CONCLUSIONS: In this patient with severe ARDS caused by Bordetella pertussis, ECMO was performed for cardiopulmonary support and rescued the infant with severe pertussis. During ECMO support period, prone position ventilation and care bundle nursing strategy contributed to the relief of continuous airway spasm.


Assuntos
Oxigenação por Membrana Extracorpórea , Pacotes de Assistência ao Paciente , Decúbito Ventral , Respiração Artificial/métodos , Síndrome Respiratória Aguda Grave/terapia , Coqueluche/complicações , Coqueluche/terapia , Espasmo Brônquico/etiologia , Espasmo Brônquico/terapia , Humanos , Lactente , Masculino , Síndrome Respiratória Aguda Grave/etiologia
4.
Paediatr Respir Rev ; 17: 63-70, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26531217

RESUMO

Pulmonary complications of childhood cancer treatment are frequently seen. These can lead to adverse sequelae many years after treatment, with important impact on morbidity, quality of life and mortality in childhood cancer survivors. This review addresses the effects of chemotherapy, radiotherapy, surgery and alloimmunity (in haematopoietic cell transplantation) on the lung in children. It highlights the complexity of lung damage and lung disease in relation to growth and development, infections and other external factors. Screening high risk childhood cancer survivors for treatment related late effects, with therapy based screening protocols, using full medical assessment and pulmonary function tests is important. This will lead to recognition of pulmonary sequelae of cancer treatment, early detection of lung damage in survivors and better treatment and prevention.


Assuntos
Antineoplásicos/efeitos adversos , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Pneumopatias/etiologia , Neoplasias/terapia , Radioterapia/efeitos adversos , Sobreviventes , Obstrução das Vias Respiratórias/etiologia , Obstrução das Vias Respiratórias/terapia , Broncopatias/etiologia , Broncopatias/terapia , Espasmo Brônquico/etiologia , Espasmo Brônquico/terapia , Criança , Tosse/etiologia , Tosse/terapia , Dispneia/etiologia , Dispneia/terapia , Humanos , Hipertensão Pulmonar/etiologia , Hipertensão Pulmonar/terapia , Hipóxia/etiologia , Hipóxia/terapia , Pneumopatias/terapia , Fibrose Pulmonar/etiologia , Fibrose Pulmonar/terapia , Pneumonite por Radiação/etiologia , Pneumonite por Radiação/terapia
5.
Am J Emerg Med ; 33(6): 857.e3-5, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25572642

RESUMO

A male patient presented with bronchospasm and acute respiratory distress. The patient had presented 2 previous episodes of severe bronchospasm following abdominal surgery, leading twice to intubation, mechanical ventilation, and conventional sedation. As the patient positively rejected a third episode of intubation + mechanical ventilation, noninvasive ventilation (pressure support = 8 cm H2O, positive end-expiratory pressure = 10 cm H2O), inhaled therapy, and clonidine orally (≈ 4 µg/kg) were combined. Over 1 to 2 hours, the acute respiratory distress disappeared. Noninvasive ventilation was discontinued on the next morning (day 2). The patient was discharged from the critical care unit on day 3 on good condition but died at a later interval from iterative bronchospasm. Evidence-based documentation of the effects of alpha-2 agonists in the setting of acute bronchospasm in the emergency department or status asthmaticus in the critical care unit is awaited.


Assuntos
Agonistas de Receptores Adrenérgicos alfa 2/uso terapêutico , Espasmo Brônquico/terapia , Clonidina/uso terapêutico , Ventilação não Invasiva , Doença Aguda , Agonistas de Receptores Adrenérgicos alfa 2/administração & dosagem , Clonidina/administração & dosagem , Evolução Fatal , Humanos , Masculino , Recidiva , Retratamento
6.
J Anesth ; 29(1): 152-5, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24993492

RESUMO

There is no strong evidence to support ventilatory management for critical limitation of expiratory flow, such as bronchospasm during anesthesia or an acute exacerbation of severe asthma and chronic obstructive pulmonary disease (COPD). Animal models cannot be used to develop reproducible experimental models for conducting mechanical ventilation strategy research relating to these etiologies due to the resulting respiratory and hemodynamic instabilities. Therefore, we developed a device model by modifying a positive end-expiratory pressure (PEEP) valve that can simulate the characteristics of airway bronchoconstriction (i.e., limited peak expiratory flow and a prolonged expiratory phase). These characteristics were found to improve upon narrowing the expiratory port. We believe that this device model will facilitate future mechanical ventilation experiments.


Assuntos
Espasmo Brônquico/terapia , Modelos Anatômicos , Asma/fisiopatologia , Espasmo Brônquico/fisiopatologia , Broncoconstrição , Simulação por Computador , Desenho de Equipamento , Humanos , Respiração com Pressão Positiva , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Respiração Artificial
7.
Br J Anaesth ; 109 Suppl 1: i47-i59, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23242751

RESUMO

Children with co-existing pulmonary disease have a wide range of clinical manifestations with significant implications for anaesthetists. Although there are a number of pulmonary diseases in children, this review focuses on two of the most common pulmonary disorders, asthma and bronchopulmonary dysplasia (BPD). These diseases share the physiology of bronchoconstriction and variably decreased flow in the airways, but also have unique physiological consequences. The anaesthetist can make a difference in outcomes with proper preoperative evaluation and appropriate preparation for surgery in the context of a team approach to perioperative care with implementation of a stepwise approach to disease management. An understanding of the importance of minimizing the risk for bronchoconstriction and having the tools at hand to treat it when necessary is paramount in the care of these patients. Unique challenges exist in the management of pulmonary hypertension in BPD patients. This review covers medical treatment, intraoperative management, and postoperative care for both patient populations.


Assuntos
Anestesia/métodos , Asma/complicações , Asma/terapia , Displasia Broncopulmonar/complicações , Displasia Broncopulmonar/terapia , Asma/fisiopatologia , Espasmo Brônquico/terapia , Displasia Broncopulmonar/fisiopatologia , Cateterismo Cardíaco , Criança , Humanos , Recém-Nascido , Cuidados Intraoperatórios , Cuidados Pós-Operatórios , Cuidados Pré-Operatórios , Gestão de Riscos
9.
Anaesthesist ; 60(10): 937-41, 2011 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-21918825

RESUMO

This article reports a case of live-threatening respiratory failure during induction of anesthesia. An 18-year-old female was admitted to hospital for an axillary abscess incision on a public holiday. The patient had a history of asthmatic episodes and an allergy to milk protein and 2 years previously an asthmatic attack had possibly been treated by mechanical ventilation. Retrospectively, this event turned out to be a cardiac arrest with mechanical ventilation for 24 h. During induction of anesthesia the patient suddenly developed massive bronchospasms and ventilation was impossible for minutes. Oxygen saturation fell below 80% over a period of 12 min with a lowest measurement of 13%. The patient was treated with epinephrine, prednisolone, antihistamine drugs, ß(2)-agonists, s-ketamine and methylxanthines and 15 min later the oxygen saturation returned to normal values. After mild therapeutic hypothermia for 24 h mechanical ventilation was still required for another 4 days. The patient recovered completely and was discharged home on day 19. Initially propofol was suspected of having caused an anaphylactic shock but in retrospect, the diagnosis of near fatal asthma was more likely. The onset of the event was facilitated by the patient playing down the history of asthmatic episodes due to a strong wish for independency and negation of the severity of the disease.


Assuntos
Anestesia por Inalação/efeitos adversos , Espasmo Brônquico/induzido quimicamente , Espasmo Brônquico/terapia , Abscesso/cirurgia , Adolescente , Antialérgicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Asma/complicações , Espasmo Brônquico/tratamento farmacológico , Broncodilatadores/uso terapêutico , Feminino , Humanos , Complicações Intraoperatórias/terapia , Hipersensibilidade a Leite/complicações , Oxigênio/sangue , Pletismografia Total , Respiração Artificial , Insuficiência Respiratória/etiologia
10.
Am J Obstet Gynecol MFM ; 2(2): 100111, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32518902

RESUMO

The worldwide incidence of coronavirus disease 2019 (COVID-19) infection is rapidly increasing, but there exists limited information on coronavirus disease 2019 in pregnancy. Here, we present our experience with 7 confirmed cases of coronavirus disease 2019 in pregnancy presenting to a single large New York City tertiary care hospital. Of the 7 patients, 5 presented with symptoms of coronavirus disease 2019, including cough, myalgias, fevers, chest pain, and headache. Of the 7 patients, 4 were admitted to the hospital, including 2 who required supportive care with intravenous hydration. Of note, the other 2 admitted patients who were asymptomatic on admission to the hospital, presenting instead for obstetrically indicated labor inductions, became symptomatic after delivery, each requiring intensive care unit admission.


Assuntos
COVID-19/terapia , Portador Sadio , Complicações Infecciosas na Gravidez/terapia , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/fisiopatologia , Adulto , Anestesia Geral , Antibacterianos/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Azitromicina/uso terapêutico , Espasmo Brônquico/terapia , COVID-19/complicações , COVID-19/diagnóstico , COVID-19/fisiopatologia , Ceftriaxona/uso terapêutico , Cesárea , Diabetes Mellitus Tipo 2/complicações , Inibidores Enzimáticos/uso terapêutico , Feminino , Febre/fisiopatologia , Pessoal de Saúde , Hospitalização , Humanos , Hidroxicloroquina/uso terapêutico , Hipertensão/complicações , Hipertensão/tratamento farmacológico , Unidades de Terapia Intensiva , Intubação Intratraqueal , Trabalho de Parto Induzido , Cidade de Nova Iorque , Nicardipino/uso terapêutico , Exposição Ocupacional , Oxigenoterapia , Hemorragia Pós-Parto/terapia , Gravidez , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/fisiopatologia , Gravidez em Diabéticas , Respiração Artificial , SARS-CoV-2 , Inércia Uterina/terapia
11.
Undersea Hyperb Med ; 36(1): 55-63, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19341128

RESUMO

The weight change per actuation and aerosol particle size and number delivered by albuterol metered dose inhalers (MDIs) were measured in a multiplace hyperbaric chamber at pressures ranging from one atmosphere absolute (1 ATA, 0 feet of seawater, fsw, 101 kPa) to three ATA (66 fsw, 304 kPa). Weight change per actuation by CFC (chlorofluorocarbon) and long canister HFA (hydrofluoroalkane) powered MDIs was 13 +/- 1% and 12 +/- 1% less, respectively, at 3 ATA compared to 1 ATA. However, weight change per actuation by short canister HFA MDIs was not significantly changed with pressure. The geometric mean diameters of nano particles from the CFC and short canister HFA MDIs decreased from 50 nm at 0 fsw to 32 nm at 66 fsw whereas the long canister HFA aerosol diameters were not affected. The numbers of nanometer size particles delivered at 66 fsw were only 4-7% of those delivered at 0 fsw for the CFC and long canister HFA MDIs whereas for the short canister MDIs it was 26%. We conclude that the weight change per actuation of albuterol and the sizes and numbers of aerosol particles emitted from albuterol MDIs actuated in a hyperbaric environment vary by canister type.


Assuntos
Albuterol/administração & dosagem , Broncodilatadores/administração & dosagem , Inaladores Dosimetrados/normas , Pressão , Aerossóis , Albuterol/química , Análise de Variância , Asma/fisiopatologia , Espasmo Brônquico/etiologia , Espasmo Brônquico/terapia , Broncodilatadores/química , Contraindicações , Mergulho/efeitos adversos , Mergulho/fisiologia , Humanos , Oxigenoterapia Hiperbárica , Nanopartículas , Tamanho da Partícula , Pesos e Medidas
12.
J Natl Med Assoc ; 111(5): 490-499, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31078287

RESUMO

BACKGROUND: Anesthesia providers in low- and middle-income countries face many challenges, including poor availability of functioning equipment designed to meet their environmental, organizational, and resource constraints. These are serious global health disparities which threaten access to care and patient safety for those who receive surgical care. In this study, we conducted a simulation-based human factors analysis of the Universal Anaesthesia Machine (UAM®), a device designed to support anesthesia providers in austere medical settings. Our team anticipated the introduction of the UAM® to the two major referral hospitals in Freetown, Sierra Leone. A prior observational study had identified these two hospitals as having environmental conditions consistent with an austere environment: an unstable electrical grid, as well as limited access to compressed oxygen, biomedical support, and consumables. Although the Baltimore simulation environment cannot reproduce all of the challenges present in a resource-constrained environment such as Sierra Leone, the major impediments to standard anesthesia machine functionality and human factors-associated use can be reproduced with the use of high-fidelity simulation. Using anesthesia care providers who have limited UAM® familiarity, this study allowed for the examination of machine-user issues in a controlled environment in preparation for further field studies concerning equipment introduction, training and device deployment in Sierra Leone. The goals of this study were: 1. to assess the usability of the UAM® (machine-user interface, simulated patient use, symbology, etc.) across different provider user groups during simulation of use in scenarios depicting routine use in healthy patients, use in clinically challenging patients and use in environmentally-challenging scenarios in a controlled setting devoid of patient risk, and 2. To gather feedback on available UAM manuals and cognitive aides and UAM usability issues in order to guide development of curricula for training providers on use of the UAM® in the intended austere clinical environments. METHODS: Residents, fellows, attending physician anesthesiologists, student nurse anesthetists, and nurse anesthetists participated in a variety of simulations involving the Universal Anaesthesia Machine® at the Johns Hopkins Medicine Simulation Center between September 2012 and July 2013. Data collected included participant demographics, performance during simulation scenarios captured with critical action checklists, workload ratings captured with the National Aeronautics and Space Administration Task Load Index (NASA TLX), and participant reactions to UAM® use captured through a post-session survey and semi-structured usability debriefing. The scenarios were: 1. normal use (machine check, induction, and maintenance of an uneventful case), 2. use in a challenging clinical condition (acute onset of bronchospasm) and 3.use in an adverse environmental event (power failure). Critical action checklists and workload ratings were analyzed by Analysis of Covariance (ANCOVA) to control for participant demographics. Usability debriefings were analyzed qualitatively. RESULTS: Thirty-five anesthesia providers participated in the study. Overall participant ratings, observations of performance in simulation scenarios, and usability debriefings indicated a high level of usability for the UAM®. Mean participant ratings were high for ease of use (5.4 ± 0.96) and clarity of instruction (6.2 ± 0.87) on a 7-point scale in which higher ratings indicate more positive perceptions. After adjusting for clinical experience, workload ratings were significantly higher in the bronchospasm scenario than in the normal/routine use (P = 0.046; 95% CI, 0.33-34.7) or power failure scenarios (P = 0.012; 95% CI, 5.24-37.9). Thirty-two specific usability issues were identified and grouped into five themes: device design and labeling, machine use during simulation scenarios, user-anticipated errors or hazards, curriculum issues, and overall impressions of the UAM®. CONCLUSIONS: The UAM® design addresses many of the key challenges facing anesthesia providers in resource-constrained settings. The simulation-based human factors evaluation described here successfully identified opportunities for continued refinement of the initial device design as well as issues to be addressed in future curricula and cognitive aides.


Assuntos
Anestesia Geral/instrumentação , Atitude do Pessoal de Saúde , Países em Desenvolvimento , Carga de Trabalho , Adulto , Anestesiologia/educação , Anestesiologia/instrumentação , Baltimore , Espasmo Brônquico/terapia , Lista de Checagem , Simulação por Computador , Currículo , Desenho de Equipamento , Ergonomia , Humanos , Sistemas Homem-Máquina , Pessoa de Meia-Idade , Simulação de Paciente , Serra Leoa
13.
J Allergy Clin Immunol Pract ; 7(7): 2194-2204.e7, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30857939

RESUMO

BACKGROUND: Despite numerous efforts to describe the clinical manifestations and the epidemiology of perioperative hypersensitivity (POH), there remains room to increase awareness among anesthetists and immunologists/allergists. OBJECTIVE: To report the findings of a 17-year survey of suspected POH in Antwerp, Belgium. METHODS: We analyzed clinical and diagnostic data from 715 patients referred because of a suspected POH reaction, between January 1, 2001, and May 31, 2018. A total of 456 patients demonstrating a POH could be queried about subsequent anesthesia. RESULTS: A total of 608 cases formed the final dataset; 208 had a non-life-threatening reaction and 400 a life-threatening reaction. In life-threatening reactions, hypotension was predominating. In the non-life-threatening reactions, 83.9% of the patients displayed cutaneous manifestations. In life-threatening reactions, intravenous adrenaline and fluids were administered in 75.7% and 31%, respectively, and 41.3% had their intervention abandoned. Mast cell activation (MCA) was mainly, but not exclusively, observed in severe grades but did not predict the mechanistic process nor the culprit. A cause was identified in 77.8% of severe and 48.6% of milder cases. Main culprits were neuromuscular blocking agents, latex, cefazolin, and dyes. A total of 156 cases had uneventful anesthesia, except 1 patient who was inadvertently re-exposed to hidden chlorhexidine. CONCLUSIONS: This study highlights that there is room for an improved acute management and an optimized diagnostic workup that should not be restricted to patients with severe reactions and/or showing MCA.


Assuntos
Anafilaxia/terapia , Hipersensibilidade a Drogas/terapia , Hipersensibilidade ao Látex/terapia , Período Perioperatório , Adulto , Anafilaxia/induzido quimicamente , Anafilaxia/diagnóstico , Anafilaxia/fisiopatologia , Angioedema/fisiopatologia , Angioedema/terapia , Antibacterianos/efeitos adversos , Anti-Infecciosos Locais/efeitos adversos , Teste de Degranulação de Basófilos , Bélgica , Espasmo Brônquico/fisiopatologia , Espasmo Brônquico/terapia , Reanimação Cardiopulmonar , Cefazolina/efeitos adversos , Criança , Clorexidina/efeitos adversos , Corantes/efeitos adversos , Toxidermias/etiologia , Toxidermias/fisiopatologia , Toxidermias/terapia , Hipersensibilidade a Drogas/diagnóstico , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/fisiopatologia , Epinefrina , Hidratação , Gelatina/efeitos adversos , Humanos , Hipotensão/fisiopatologia , Hipotensão/terapia , Imunoglobulina E/metabolismo , Testes Intradérmicos , Hipersensibilidade ao Látex/diagnóstico , Hipersensibilidade ao Látex/etiologia , Hipersensibilidade ao Látex/metabolismo , Mastócitos , Azul de Metileno/efeitos adversos , Bloqueadores Neuromusculares/efeitos adversos , Corantes de Rosanilina/efeitos adversos , Índice de Gravidade de Doença , Testes Cutâneos , Simpatomiméticos/uso terapêutico , Triptases/metabolismo
15.
Einstein (Sao Paulo) ; 16(4): eAO4199, 2018 Nov 08.
Artigo em Inglês, Português | MEDLINE | ID: mdl-30427479

RESUMO

OBJECTIVE: To evaluate if distress respiratory decreases after using helium-oxygen mixture in pediatric patients diagnosed with bronchospasm. METHODS: This is a retrospective, non-randomized study that included patients diagnosed with bronchospasm, who received a helium-oxygen mixture at three time points (30, 60, and 120 minutes) according to the organization protocol singular, and were admitted to the intensive care unit, from January 2012 to December 2013. This protocol includes patients with bronchospasm who sustained a modified Wood score of moderate to severe, even after one hour of conventional treatment. RESULTS: Twenty children were included in the study. The mean score of severity of the disease at the initial moment was 5.6 (SD:2.0), and at moment 120 minutes, it was 3.4 (SD: 2.0). The severity score showed a significant improvement as of 30 minutes (p<0.001). CONCLUSION: The use of helium-oxygen mixture proved to be effective in diminishing the respiratory distress score for children with airway obstructions; it should be considered a supplementary therapeutic option, together with drug therapy, in specific clinical situations.


Assuntos
Espasmo Brônquico/terapia , Hélio/administração & dosagem , Oxigenoterapia/métodos , Criança , Pré-Escolar , Feminino , Humanos , Unidades de Terapia Intensiva Pediátrica , Masculino , Ensaios Clínicos Controlados não Aleatórios como Assunto , Estudos Retrospectivos , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento
16.
Anaesth Crit Care Pain Med ; 37(2): 161-166, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28882740

RESUMO

BACKGROUND: Sleep deprivation has been associated with an increased incidence of medical errors and can jeopardise patients' safety during medical crisis management. The aim of the study was to assess the effect of sleep deprivation on the management of simulated anaesthesia crisis by residents in anaesthesiology. METHODS: A randomised, comparative, monocentric crossover study involving 48 residents in anaesthesia was performed on a high fidelity patient simulator. Each resident was evaluated in a sleep-deprived state (deprived group, after a night shift duty) and control state (control group, after a night of sleep). Performance was assessed through points obtained during crisis scenario 1 (oesophageal intubation followed by anaphylactic shock) and scenario 2 (anaesthesia-related bronchospasm followed by ventricular tachycardia). Sleep periods were recorded by actigraphy. Two independent observers assessed the performances. The primary endpoint of the study was the score obtained for each scenario. RESULTS: Resident's crisis management performance is associated with sleep deprivation (scenario 1: control=39 [33-42] points vs. deprived=26 [19-40] points, P=0.02; scenario 2: control=21 [17-24] vs. deprived=14 [12-19], P=0.01). The main errors observed were: error in drug administration and dose, delay in identification of hypotension, and missing communication with the surgical team about situation. CONCLUSIONS: The present study showed that sleep deprivation is associated with impairment of performance to manage crisis situations by residents in anaesthesia.


Assuntos
Anestesiologistas , Anestesiologia/educação , Internato e Residência , Privação do Sono/psicologia , Transtornos do Sono do Ritmo Circadiano/psicologia , Adulto , Anafilaxia/terapia , Anestesia/efeitos adversos , Espasmo Brônquico/terapia , Competência Clínica , Estudos Cross-Over , Serviços Médicos de Emergência , Feminino , Humanos , Hipotensão/diagnóstico , Intubação Intratraqueal , Masculino , Erros Médicos , Simulação de Paciente
17.
Rev Pneumol Clin ; 74(6): 416-426, 2018 Dec.
Artigo em Francês | MEDLINE | ID: mdl-30442511

RESUMO

INTRODUCTION: Scuba diving has long been contraindicated for asthmatics. Recommendations are evolving towards authorisation under certain conditions. Our objective was to review the literature on the risks associated with scuba diving among asthmatics and about recommendations on this subject. MATERIALS AND METHODS: We used the MEDLINE and LiSSa databases, until June 2018, in French, English or Spanish language, with the keywords "asthma AND diving" and "asthme plongée" respectively. References to the first degree were analyzed. RESULTS: We have included 65 articles. Risk of bronchospasm is well documented, particularly in cold and/or deep water, or in the event of exposure to allergens (compressor without filter). Nonasthmatic atopic divers may be at greater risk of developing bronchial hyper-reactivity. Although the theoretical risk exists, epidemiological studies do not seem to show an over-risk of barotrauma, decompression sickness or arterial gas embolism in asthmatics. French, British, American, Spanish and Australian societies agreed on the exclusion of patients with moderate to severe persistent asthma, FEV1<80%, active asthma in the last 48hours, exercise/cold asthma and poor physical fitness. CONCLUSION: A diver's examination should include a triple assessment: asthma control, number of exacerbations and treatment compliance. Homogenizing the recommendations would improve the framework for the practice of diving among asthmatics and allow larger studies in this population. Communicating the current recommendations remains important to divers, dive instructors and doctors in the context of the development of scuba diving.


Assuntos
Asma/terapia , Mergulho/fisiologia , Asma/epidemiologia , Asma/etiologia , Barotrauma/epidemiologia , Barotrauma/etiologia , Barotrauma/terapia , Espasmo Brônquico/epidemiologia , Espasmo Brônquico/etiologia , Espasmo Brônquico/terapia , Doença da Descompressão/epidemiologia , Doença da Descompressão/etiologia , Doença da Descompressão/terapia , Mergulho/efeitos adversos , Mergulho/estatística & dados numéricos , Humanos , Fatores de Risco
18.
Clin Toxicol (Phila) ; 56(2): 126-131, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28748745

RESUMO

BACKGROUND: Insect consumption is a common practice in the Asian culture and all over the world. We are reporting an outbreak investigation of histamine poisoning from ingestion of fried insects. METHODS: On 24 July 2014, a group of students at a seminar presented to Angthong Provincial Hospital, Thailand, with pruritic rash after ingesting snacks consisting of fried insects from a vendor. We initiated an outbreak investigation with retrospective cohort design and collected samples of remaining foods for analyses. Attack rates, relative risks and their confidence intervals (CI) were calculated. RESULTS: Out of 227 students, 28 developed illnesses that were consistent with our case definition which included, flushing, pruritus, urticarial rashes, headache, nausea, vomiting, diarrhea, dyspnea and bronchospasm. Two children were hospitalized for progressive bronchospasm overnight without serious complications. The types of food ingested included a lunch that was provided at the seminar for all students and snacks that 41 students bought from the only vendor in the vicinity. The snacks included fried grasshoppers, silkworm pupae, common green frogs, bamboo borers, crickets and meat balls. The attack rates were highest (82.6 and 85.0%) among students who ingested fried grasshoppers and silkworm pupae and lowest (4.4 and 5.3%) among those who did not ingest them, with relative risk of 18.7 (95% CI 9.6-36.4) for grasshoppers and 16.0 (95% CI 8.8-29.3) for silkworm pupae. Histamine concentrations in the fried grasshoppers and silkworm pupae were 9.73 and 7.66 mg/100g, respectively. DISCUSSION AND CONCLUSION: Through epidemiological analysis and laboratory confirmation, we have illustrated that histamine poisoning can occur from ingestion of fried insects. We postulate that histidine, which is present in high concentration in grasshoppers and silkworm pupae, is decarboxylated by bacteria to histamine, a heat stable toxin. The ingestion of histamine is responsible for the clinical pictures being reported.


Assuntos
Surtos de Doenças , Doenças Transmitidas por Alimentos/epidemiologia , Histamina/intoxicação , Insetos , Adolescente , Animais , Bombyx/química , Espasmo Brônquico/induzido quimicamente , Espasmo Brônquico/terapia , Estudos de Coortes , Exantema/induzido quimicamente , Feminino , Gafanhotos/química , Histidina/metabolismo , Histidina/intoxicação , Hospitalização , Humanos , Insetos/química , Masculino , Prurido/induzido quimicamente , Estudos Retrospectivos , Tailândia/epidemiologia , Adulto Jovem
19.
Ther Adv Respir Dis ; 12: 1753466618777723, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29865929

RESUMO

BACKGROUND: Asthma is characterized by hyperresponsiveness of the airways, and exercise-induced bronchospasm (EIB) is a symptom that limits a large proportion of asthmatic patients, especially children. Continuous positive airway pressure (CPAP) leads to a reduction in the reactivity of the airways. The aim of this study was to evaluate the effect of outpatient treatment with CPAP and bilevel pressure combined with respiratory physical therapy for children and adolescents with asthma following bronchial hyperresponsiveness caused by an exercise bronchoprovocation test. METHODS: A randomized, controlled, blind, clinical trial was conducted involving 68 asthmatic children and adolescents aged 4 to 16 years divided into three groups: G1, treated with bilevel pressure (inspiratory positive airway pressure: 12 cm H2O; expiratory positive airway pressure: 8 cm H2O), G2, treated with CPAP (8 cm H2O) and G3, treated with respiratory muscle training (RMT), considered as the control group. All groups were treated at an outpatient clinic and submitted to 10 1-hour sessions, each of which also included respiratory exercises. Evaluations were performed before and after treatment and involved spirometry, an exercise bronchoprovocation test, respiratory pressures, fraction of nitric oxide (FeNO), the Asthma Control Questionnaire (ACQ6) and anthropometric variables. This study received approval from the local ethics committee (certificate number: 1487225/2016) and is registered with ClinicalTrials [ ClinicalTrials.gov identifier: NCT02939625]. RESULTS: A total of 64 patients concluded the protocol; the mean age of the patients was 10 years. All were in the ideal weight range and had adequate height ( z score: -2 to +2). The three groups demonstrated improved asthma control after the treatments, going from partial to complete control. A significant increase in maximal inspiratory pressure occurred in the three groups, with the greatest increase in the RMT group. A reduction in FeNO in the order of 17.4 parts per billion (effect size: 2.43) and a reduction in bronchial responsiveness on the exercise bronchoprovocation test occurred in the bilevel group. An improvement in FeNO on the order of 15.7 parts per billion (effect size: 2.46) and a reduction in bronchial responsiveness occurred in the CPAP group. No changes in lung function or responsiveness occurred in the RMT group. CONCLUSION: Positive pressure and respiratory exercises were effective in reducing pulmonary inflammation, exercise-innduced bronchoespasm (EIB), and increased the clinical control of asthma, as well as RMT, which also resulted in improved clinical control.


Assuntos
Asma Induzida por Exercício/terapia , Exercícios Respiratórios , Espasmo Brônquico/terapia , Broncoconstrição , Pressão Positiva Contínua nas Vias Aéreas , Pulmão/fisiopatologia , Ventilação não Invasiva , Pneumonia/terapia , Terapia Respiratória/métodos , Adolescente , Fatores Etários , Asma Induzida por Exercício/diagnóstico , Asma Induzida por Exercício/fisiopatologia , Brasil , Exercícios Respiratórios/efeitos adversos , Espasmo Brônquico/diagnóstico , Espasmo Brônquico/fisiopatologia , Criança , Pré-Escolar , Terapia Combinada , Pressão Positiva Contínua nas Vias Aéreas/efeitos adversos , Feminino , Humanos , Masculino , Ventilação não Invasiva/efeitos adversos , Pneumonia/diagnóstico , Pneumonia/fisiopatologia , Terapia Respiratória/efeitos adversos , Fatores de Tempo , Resultado do Tratamento
20.
Anesth Prog ; 54(2): 59-68; quiz 69, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17579505

RESUMO

The risk for complications while providing moderate and deep sedation is greatest when caring for patients already medically compromised. It is reassuring that significant untoward events can generally be prevented by careful preoperative assessment, along with attentive intraoperative monitoring and support. Nevertheless, we must be prepared to manage untoward events should they arise. This continuing education article will review critical aspects of patient management of respiratory and cardiovascular complications.


Assuntos
Anestesia Geral , Sedação Consciente , Cardiopatias/terapia , Doenças Respiratórias/terapia , Obstrução das Vias Respiratórias/terapia , Anestesia Geral/efeitos adversos , Angina Pectoris/terapia , Arritmia Sinusal/terapia , Pressão Sanguínea/fisiologia , Espasmo Brônquico/terapia , Sedação Consciente/efeitos adversos , Emergências , Parada Cardíaca/terapia , Cardiopatias/prevenção & controle , Humanos , Hipertensão/terapia , Hipotensão/terapia , Máscaras Laríngeas , Laringismo/terapia , Cuidados para Prolongar a Vida , Máscaras , Infarto do Miocárdio/terapia , Oxigenoterapia/instrumentação , Respiração com Pressão Positiva , Transtornos Respiratórios/prevenção & controle , Transtornos Respiratórios/terapia , Doenças Respiratórias/prevenção & controle , Volume Sistólico/fisiologia , Taquicardia/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA